From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

So this is a drug that's still in development. So this is GS-1720. It's been studied as single doses in healthy volunteers ...

To end the Latino HIV crisis, health programs must be developed, tailored and evolve to meet the health needs and preferences of our diverse Latino communities.

Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...

Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...

Joseph Kibler and his wife, Carey Cox, shared that they're expecting a baby who will be HIV-negative, despite Kibler's ...

The free contraceptives will be accompanied by 45,500 educational pamphlets on HIV/AIDS, 3,000 pre- and post-exposure ...

In honor of World AIDs Day, the Coastal Health District (CHD) is offering three free HIV testing events in Savannah. At two ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Serious questions are being raised about what led to the limited supply of crucial HIV medication, prompting the Health ...

HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or ...